Skip to main content

Table 5 Characteristics of the use cases

From: Synthesizing evidence from clinical trials with dynamic interactive argument trees

Disease SRs No. RCTs Dimensions {sub-dimensions} Compared drugs
Glaucoma Zhang et al. [19] 11 efficacy {IOP reduction}, safety {conjunctival hyperemia} latanoprost / timolol
T2DM Rys et al. [20] 9 efficacy {reduction of HbA1c}, safety {hypoglycemia} insulin glargine / NPH insulin